Scolaris Content Display Scolaris Content Display

Antibiotics versus topical antiseptics for chronic suppurative otitis media

Esta versión no es la más reciente

ver la versión actual 05 enero 2020

Referencias

Additional references

Baumann 2011

Baumann I, Gerendas B, Plinkert PK, Praetorius M. General and disease‐specific quality of life in patients with chronic suppurative otitis media‐‐a prospective study. Health and Quality of Life Outcomes 2011;9:48. [DOI: 10.1186/1477‐7525‐9‐48]

Bhutta 2011

Bhutta MF, Williamson IG, Sudhoff HH. Cholesteatoma. BMJ 2011;342:d1088. [DOI: 10.1136/bmj.d1088]

Bhutta 2016

Bhutta MF. Evolution and otitis media: a review, and a model to explain high prevalence in indigenous populations. Human Biology 2016;87(2):92‐108.

Bhutta 2018

Bhutta MF, Head K, Chong LY, Tu N, Schilder AGM, Burton MJ, et al. Aural toilet for chronic suppurative otitis media. Cochrane Database of Systematic Reviews 2018, Issue 6.

Brennan‐Jones 2018a

Brennan‐Jones CG, Head K, Chong LY, Tu N, Burton MJ, Schilder AGM, et al. Topical antibiotics for chronic suppurative otitis media. Cochrane Database of Systematic Reviews 2018, Issue 6.

Brennan‐Jones 2018b

Brennan‐Jones CG, Chong LY, Head K, Tu N, Burton MJ, Schilder AGM, et al. Topical antibiotics with steroids for chronic suppurative otitis media. Cochrane Database of Systematic Reviews 2018, Issue 6.

Chong 2018a

Chong LY, Head K, Richmond P, Snelling T, Schilder AGM, Burton MJ, et al. Systemic antibiotics for chronic suppurative otitis media. Cochrane Database of Systematic Reviews 2018, Issue 6.

Chong 2018b

Chong LY, Head K, Richmond P, Snelling T, Schilder AGM, Burton MJ, et al. Topical versus systemic antibiotics for chronic suppurative otitis media. Cochrane Database of Systematic Reviews 2018, Issue 6.

Dubey 2007

Dubey SP, Larawin V. Complications of chronic suppurative otitis media and their management. Laryngoscope 2007;117(2):264‐7.

Egger 1997

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34.

Elbourne 2002

Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140‐9.

Elemraid 2010

Elemraid MA, Brabin BJ, Fraser WD, Harper G, Faragher B, Atef Z, et al. Characteristics of hearing impairment in Yemeni children with chronic suppurative otitis media: a case‐control study. International Journal of Pediatric Otorhinolaryngology 2010;74(3):283‐6.

Gates 2002

Gates GA, Klein JO, Lim DJ, Mogi G, Ogra PL, Pararella MM, et al. Recent advances in otitis media. 1. Definitions, terminology, and classification of otitis media. Annals of Otology, Rhinology & Laryngology. Supplement 2002;188:8‐18.

Gupta 2015

Gupta C, Agrawal A, Gargav ND. Role of acetic acid irrigation in medical management of chronic suppurative otitis media: a comparative study. Indian Journal of Otolaryngology 2015;67(3):314–8. [DOI: 10.1007/s12070‐014‐0815‐2]

Handbook 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Head 2018a

Head K, Chong LY, Bhutta MF, Morris PS, Vijayasekaran S, Burton MJ, et al. Topical antiseptics for chronic suppurative otitis media. Cochrane Database of Systematic Reviews 2018, Issue 6.

Head 2018b

Head K, Chong LY, Bhutta MF, Morris PS, Vijayasekaran S, Burton MJ, et al. Antibiotics versus topical antiseptics for chronic suppurative otitis media. Cochrane Database of Systematic Reviews 2018, Issue 6.

Jensen 2013

Jensen RG, Koch A, Homøe P. The risk of hearing loss in a population with a high prevalence of chronic suppurative otitis media. International Journal of Pediatric Otorhinolaryngology 2013;77(9):1530‐5. [DOI: 10.1016/j.ijporl.2013.06.025]

Mahadevan 2012

Mahadevan M, Navarro‐Locsin G, Tan HK, Yamanaka N, Sonsuwan N, Wang PC, et al. A review of the burden of disease due to otitis media in the Asia‐Pacific. International Journal of Pediatric Otorhinolaryngology 2012;76(5):623‐35. [DOI: 10.1016/j.ijporl.2012.02.031]

McDonnell 1999

McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clinical Microbiology Reviews 1999;12:147–79.

Mittal 2015

Mittal R, Lisi CV, Gerring R, Mittal J, Mathee K, Narasimhan G, et al. Current concepts in the pathogenesis and treatment of chronic suppurative otitis media. Journal of Medical Microbiology 2015;64(10):1103‐16. [DOI: 10.1099/jmm.0.000155]

Monasta 2012

Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A, et al. Burden of disease caused by otitis media: systematic review and global estimates. PloS One 2012;7(4):e36226.

Nadol 2000

Nadol JB, Staecker H, Gliklich RE. Outcomes assessment for chronic otitis media: the Chronic Ear Survey. Laryngoscope 2000;110(3 Pt 3):32‐5. [DOI: 10.1097/00005537‐200003002‐00009]

Olatoke 2008

Olatoke F, Ologe FE, Nwawolo CC, Saka MJ. The prevalence of hearing loss among schoolchildren with chronic suppurative otitis media in Nigeria, and its effect on academic performance. Ear, Nose, & Throat Journal 2008;87(12):E19.

Orji 2013

Orji F. A survey of the burden of management of chronic suppurative otitis media in a developing country. Annals of Medical and Health Sciences Research 2013;4(3):598‐601. [DOI: 10.4103/2141‐9248.122126]

Phillips 2007

Phillips JS, Yung MW, Burton MJ, Swan IR. Evidence review and ENT‐UK consensus report for the use of aminoglycoside‐containing ear drops in the presence of an open middle ear. Clinical Otolaryngology 2007;32(5):330‐6.

Phillips 2014a

Phillips JS, Yung MW. COMQ‐12 scores in adult patients without chronic middle ear disease. Clinical Otolaryngology 2014;39(6):362‐7. [DOI: 10.1111/coa.12306]

Phillips 2014b

Phillips JS, Haggard M, Yung M. A new health‐related quality of life measure for active chronic otitis media (COMQ‐12): development and initial validation. Otology & Neurotology 2014;35(3):454‐8. [DOI: 10.1097/mao.0000000000000205]

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Schilder 2016

Schilder AG, Chonmaitree T, Cripps AW, Rosenfeld RM, Casselbrant ML, Haggard MP, et al. Otitis media. Nature Reviews Disease Primers 2016;2:16063. [DOI: 10.1038/nrdp.2016.63]

Sheldon 2005

Sheldon AT. Antiseptic "resistance": real or perceived threat?. Clinical Infectious Diseases 2005;40(11):1650‐6.

Stedman 2011

Stedman MR, Curtin F, Elbourne DR, Kesselheim AS, Brookhart MA. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2011;40(6):1732‐4. [DOI: 10.1093/ije/dyp345]

van der Veen 2006

van der Veen EL, Schilder AG, van Heerbeek N, Verhoeff M, Zielhuis GA, Rovers MM. Predictors of chronic suppurative otitis media in children. Archives of Otolaryngology‐‐Head & Neck Surgery 2006;132(10):1115‐8. [DOI: 10.1001/archotol.132.10.1115]

van Dinther 2015

van Dinther J, Droessaert V, Camp S, Vanspauwen R, Maryn Y, Zarowski A, et al. Validity and test‐retest reliability of the Dutch Version of the Chronic Otitis Media Questionnaire 12 (COMQ‐12). Journal of International Advanced Otology 2015;11(3):248‐52. [DOI: 10.5152/iao.2015.1701]

Verhoeff 2006

Verhoeff M, van der Veen EL, Rovers MM, Sanders EA, Schilder AG. Chronic suppurative otitis media: a review. International Journal of Pediatric Otorhinolaryngology 2006;70(1):1‐12.

WHO 2004

World Health Organization. Chronic Suppurative Otitis Media (CSOM): Burden of Illness and Management Options. Geneva, Switzerland: World Health Organization, 2004.

Yorgancılar 2013

Yorgancılar E, Yildirim M, Gun R, Bakir S, Tekin R, Gocmez C, et al. Complications of chronic suppurative otitis media: a retrospective review. European Archives of Oto‐rhino‐laryngology 2013;270(1):69‐76. [DOI: 10.1007/s00405‐012‐1924‐8]
Table 1. Table of Cochrane Reviews

Topical antibiotics with steroids

Topical antibiotics

Systemic antibiotics

Topical antiseptics

Aural toileting (ear cleaning)

Topical antibiotics with steroids

Review CSOM‐4

Topical antibiotics

Review CSOM‐4

Review CSOM‐1

Systemic antibiotics

Review CSOM‐4

Review CSOM‐3

Review CSOM‐2

Topical antiseptics

Review CSOM‐4

Review CSOM‐6

Review CSOM‐6

Review CSOM‐5

Aural toileting

Review CSOM‐4

Not reviewed

Not reviewed

Not reviewed

Review CSOM‐7

Placebo (or no intervention)

Review CSOM‐4

Review CSOM‐1

Review CSOM‐2

Review CSOM‐5

Review CSOM‐7

CSOM‐1: Topical antibiotics for chronic suppurative otitis media (Brennan‐Jones 2018a).

CSOM‐2: Systemic antibiotics for chronic suppurative otitis media (Chong 2018a).

CSOM‐3: Topical versus systemic antibiotics for chronic suppurative otitis media (Chong 2018b).

CSOM‐4: Topical antibiotics with steroids for chronic suppurative otitis media (Brennan‐Jones 2018b).

CSOM‐5: Topical antiseptics for chronic suppurative otitis media (Head 2018a).

CSOM‐6: Antibiotics versus topical antiseptics for chronic suppurative otitis media (Head 2018b).

CSOM‐7: Aural toilet (ear cleaning) for chronic suppurative otitis media (Bhutta 2018).

Figuras y tablas -
Table 1. Table of Cochrane Reviews
Ir a la tabla del protocolo
Table 2. Examples of antibiotics classes and agents with anti‐Pseudomonas activity

Class of antibiotics

Examples

Route of administration

Quinolones

Ciprofloxacin, ofloxacin, levofloxacin

Oral, intravenous, topical

Aminoglycosides

Gentamicin, tobramycin

Topical or parenteral

Neomycin/framycetin

Only topical

Cephalosporins

Ceftazidime

Parenteral

Penicillins

Ticarcillin plus clavulanic acid

Parenteral

Monobactams

Aztreonam

Parenteral
Figuras y tablas -
Table 2. Examples of antibiotics classes and agents with anti‐Pseudomonas activity
Ir a la tabla del protocolo
Table 3. Antiseptics that have been used to treat CSOM

Antiseptic agent used aurally

Target and mechanism of action

Rubbing alcohol (ethanol, isopropanol)

Penetrating agents that cause loss of cellular membrane function, leading to release of intracellular components, denaturing of proteins, and inhibition of DNA, RNA, protein and peptidoglycan synthesis.

Povidone iodine

Highly active oxidising agents that destroy cellular activity of proteins. Disrupts oxidative phosphorylation and membrane‐associated activities. Iodine reacts with cysteine and methionine thiol groups, nucleotides and fatty acids, resulting in cell death.

Chlorhexidine

Membrane‐active agents that damage cell wall and outer membrane, resulting in collapse of membrane potential and intracellular leakage. Enhanced passive diffusion mediates further uptake, causing coagulation of cytosol.

Hydrogen peroxide

Produces hydroxyl free radicals that function as oxidants, which react with lipids, proteins and DNA. Sulfhydryl groups and double bonds are targeted in particular, thus increasing cell permeability.

Boric acid

It is likely that the change in the pH media of the ear canal interrupts the growth of bacteria by affecting the amino acid, which causes alteration in the three‐dimensional structure of bacterial enzymes. Extreme changes in pH cause protein denaturation.

Aluminium acetate/acetic acid

Acetic acid changes the pH media of the ear canal and interrupts the growth of bacteria by affecting the amino acid, which causes alteration in the three‐dimensional structure of bacterial enzymes. Extreme changes in pH cause protein denaturation. Aluminium acetate is an astringent that helps reduce itching, stinging and inflammation.

Sources: Gupta 2015; McDonnell 1999; Sheldon 2005.

Figuras y tablas -
Table 3. Antiseptics that have been used to treat CSOM
Ir a la tabla del protocolo